352 related articles for article (PubMed ID: 31416160)
1. PML Bodies in Mitosis.
Lång A; Lång E; Bøe SO
Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
[TBL] [Abstract][Full Text] [Related]
2. Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis.
Chen YC; Kappel C; Beaudouin J; Eils R; Spector DL
Mol Biol Cell; 2008 Jul; 19(7):3147-62. PubMed ID: 18480407
[TBL] [Abstract][Full Text] [Related]
3. Influence of acute promyelocytic leukemia therapeutic drugs on nuclear pore complex density and integrity.
Lång A; Øye A; Eriksson J; Rowe AD; Lång E; Bøe SO
Biochem Biophys Res Commun; 2018 May; 499(3):570-576. PubMed ID: 29596829
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukemia bodies tether to early endosomes during mitosis.
Palibrk V; Lång E; Lång A; Schink KO; Rowe AD; Bøe SO
Cell Cycle; 2014; 13(11):1749-55. PubMed ID: 24675887
[TBL] [Abstract][Full Text] [Related]
5. PML bodies: a meeting place for genomic loci?
Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
[TBL] [Abstract][Full Text] [Related]
6. PML Nuclear bodies: the cancer connection and beyond.
Abou-Ghali M; Lallemand-Breitenbach V
Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
8. The nuclear bodies inside out: PML conquers the cytoplasm.
Carracedo A; Ito K; Pandolfi PP
Curr Opin Cell Biol; 2011 Jun; 23(3):360-6. PubMed ID: 21501958
[TBL] [Abstract][Full Text] [Related]
9. Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?
Borden KL
Biochim Biophys Acta; 2008 Nov; 1783(11):2145-54. PubMed ID: 18616965
[TBL] [Abstract][Full Text] [Related]
10. Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1.
Dellaire G; Eskiw CH; Dehghani H; Ching RW; Bazett-Jones DP
J Cell Sci; 2006 Mar; 119(Pt 6):1034-42. PubMed ID: 16492707
[TBL] [Abstract][Full Text] [Related]
11. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.
Voisset E; Moravcsik E; Stratford EW; Jaye A; Palgrave CJ; Hills RK; Salomoni P; Kogan SC; Solomon E; Grimwade D
Blood; 2018 Feb; 131(6):636-648. PubMed ID: 29191918
[TBL] [Abstract][Full Text] [Related]
12. The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH; Bazett-Jones DP
Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
[TBL] [Abstract][Full Text] [Related]
13. PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein.
Daniels MJ; Marson A; Venkitaraman AR
Nat Struct Mol Biol; 2004 Nov; 11(11):1114-21. PubMed ID: 15467728
[TBL] [Abstract][Full Text] [Related]
14. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
15. Expression of the promyelocytic leukemia protein without the nuclear localization signal as a novel diagnostic marker for acute promyelocytic leukemia.
Xu T; Yang XQ; Jiang KL; Wang H; Ma PP; Zhong L; Liu BZ
Oncol Rep; 2017 Feb; 37(2):986-994. PubMed ID: 28075463
[TBL] [Abstract][Full Text] [Related]
16. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
17. The Role of Non-Specific Interactions in Canonical and ALT-Associated PML-Bodies Formation and Dynamics.
Fonin AV; Silonov SA; Shpironok OG; Antifeeva IA; Petukhov AV; Romanovich AE; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072343
[TBL] [Abstract][Full Text] [Related]
18. The functional roles of PML nuclear bodies in genome maintenance.
Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
[TBL] [Abstract][Full Text] [Related]
19. PML nuclear bodies and other TRIM-defined subcellular compartments.
Batty EC; Jensen K; Freemont PS
Adv Exp Med Biol; 2012; 770():39-58. PubMed ID: 23630999
[TBL] [Abstract][Full Text] [Related]
20. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
